ArticleJapanese journal of radiology2026
Additional diagnostic value of lesion visibility on diffusion-weighted imaging for differentiating BI-RADS category 4 MRI-detected breast lesions.
Article in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate whether adding diffusion-weighted imaging (DWI) to dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) improves the differentiation between nonmalignant and malignant MRI-detected lesions. MATERIALS AND
methodsA total of 36 patients with 40 Breast Imaging-Reporting and Data System (BI-RADS) category 4 MRI-detected lesions were analyzed. Two readers independently evaluated lesion visibility on two b-value DWIs (b = 800 s/mm
resultsThe inter-observer agreement of the DWI visibility score was substantial for both DWI
conclusionThe present findings suggest that DWI visibility provides additional value for distinguishing between nonmalignant and malignant BI-RADS category 4 MRI-detected breast lesions. Particularly for mass lesions, DWI-negative MRI-detected lesions were associated with nonmalignant pathology, indicating a potential role for DWI in reducing unnecessary biopsies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.